ITMCTR2100005369尚未招募1 期
Oral etoposide combined with realgar natural indigo tablets and all-trans retinoic acid in the treatment of high-risk acute promyelocytic leukemia
People's Hospital, Institute of Hematology, Peking University0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 性别
- Male
入选标准
- •1)Newly diagnosed high-risk APL(WHO classification 2016);2) Age from 18-70(18 and 70 are included);3) Without uncontrolled active infection;4) Without organ failure;5) Liver function:serum ALT and AST=2.5*ULN,serum bilirubin=2.0*ULN;6) Kidney function:serum Cr=3.0*
排除标准
- •1) With cerebral hemorrhage; 2) Gestation;3) Suffering from mental illness or other conditions that cannot be carried out according to the scheme;4) Unable to take oral drugs;5) Uncontrolled active infection;6) Organ failure; 7) Allergic to etoposide.
研究者
相似试验
进行中（未招募）
2 期
Saponins for macular diseaseMen and women with early or intermediate stage age-related macular degeneration (AMD) in the trial eye and any stage of AMD in the non-trial eyeEye DiseasesISRCTN82949875Cardiff University60
进行中（未招募）
不适用
A food compound with a preventive effect and / or treatment in lipid and glycemic disordersIn HIV-positive individuals on antiretroviral therapyRBR-6m2fchniversidade Federal de Mato Grosso do Sul
招募中
4 期
Oral indomethacin for the prevention of post-ERCP pancreatitis: A Randomized Controlled Trialpost-ERCP complications (including bleeding,biliary infection,perforation and any adverse outcomes requiring hospital admission or prolonged hospital stay for further management) were monitored. PatPost-ERCP pancreatitisTCTR20190218006The Gastroenterological Association of Thailand350
已完成
3 期
CITOPROT-IIIDiabetic foot ulcer.Foot UlcerLeg UlcerSkin UlcerDiabetic AngiopathiesVascular DiseasesDiabetes ComplicationsDiabetic NeuropathiesEndocrine System DiseasesCardiovascular DiseasesDiabetes MellitusDiabetic FootRPCEC00000060Center for Genetic Engineering and Biothecnology (CIGB), Havana.147
进行中（未招募）
不适用
Oral treatment of allergy with a non-pathogenic microorganism: A randomised clinical trial - TSO-01MedDRA version: 9.1Level: LLTClassification code 10001723Term: Allergic rhinitisAllergic rhinitisEUCTR2007-006099-12-DKStatens Serum Institut